; and (ii) the extent to which each participating oncology practice has, during such year, used breakthrough or other best-in-class therapies. (B) Performance standards The Secretary shall, in consultation with the appropriate stakeholders described in paragraph (3)(B) in a manner determined by the Secretary, develop performance standards with respect to— (i) each of the measures described in paragraph (2), including those measures as modified or added under paragraph (3); and (ii) the patient experience of care on which participating oncology practices agree to report to the Secretary under subsection (c)(6)(B). (f) Payments for participating oncology practices and oncologists (1) Care coordination management fee during first two years of demonstration project (A) In general The Secretary shall, in addition to any other payments made by the Secretary under this title to a participating oncology practice, pay a care coordination management fee to each such practice at each of the times specified in subparagraph (B). (B) Timing of payments The care coordination management fee described in subparagraph (A) shall be paid to a participating oncology practice at the end of each of the following periods: (i) The period that ends 6 months after the date on which the practice’s agreement period for the demonstration project begins, as determined by the Secretary. (ii) The period that ends 12 months after the date on which the practice’s agreement period for the demonstration project begins, as determined by the Secretary. (iii) Subject to subsection (c)(7)— (I) the period that ends 18 months after the date on which the practice’s agreement period for the demonstration project begins, as determined by the Secretary